Home Empaphage Tablets 10mg
Empaphage Tablets 10mg – Available in Pakistan
Klaribact 125mg/5ml Suspension — Derma.pk product image – View Product Detail
Empaphage Tablets 10mg – Available in Pakistan
Klaribact 125mg/5ml Suspension — Derma.pk product image – View Product Detail

Empaphage Tablets 10mg

Empaphage Tablets 10mg contain empagliflozin (SGLT2 inhibitor) for Rx management of type 2 diabetes mellitus in adults. Lowers blood glucose by increasing urinary glucose excretion. Used as monotherapy or combination therapy. Also reduces cardiovascular risk. Prescription required. Available at Derma.pk Pakistan.

Sale price Rs. 310

Pay in 3 Installments of

Rs.

118

  • Oxagit Doxazosin 2mg Tablets – Available in Pakistan
    Oxagit Doxazosin 2mg Tablets
    Sale priceRs. 468
  • 20% SA + Clobetasol Ointment – Available in Pakistan
    20% SA + Clobetasol Ointment
    Sale priceRs. 1,110
  • Cholce-D Vitamin D3 200,000 IU IM Injection – Available in Pakistan
    Cholce-D Vitamin D3 200,000 IU IM Injection
    Sale priceRs. 203
Availability: In stock SKU: derma.pk-5457-109-067
Tags: Anti-Diabetic Tablets Blood Sugar Control Cardiovascular Risk Reduction Diabetes Medicine Pakistan Empagliflozin 10mg Empagliflozin Pakistan Empaphage 10mg Prescription Diabetes Medicine SGLT2 Inhibitor 2 Diabetes Treatment
Empaphage Tablets 10mg – Available in Pakistan

Empaphage Tablets 10mg

Rs. 310

Empaphage Tablets 10mg – Empagliflozin (SGLT2 Inhibitor) for Type 2 Diabetes

Empaphage Tablets 10mg contain empagliflozin, a selective sodium-glucose co-transporter 2 (SGLT2) inhibitor prescribed for the management of type 2 diabetes mellitus in adults. By blocking SGLT2 in the proximal tubule of the kidney, empagliflozin reduces reabsorption of filtered glucose, thereby increasing urinary glucose excretion and lowering blood glucose levels. A prescription is required.

  • Contains empagliflozin 10mg — a selective SGLT2 inhibitor
  • Reduces blood glucose by promoting urinary excretion of glucose
  • Used as monotherapy or in combination with other antidiabetics including insulin
  • Clinically shown to reduce cardiovascular risk in T2DM patients
  • Prescription-only medicine — requires valid Rx from doctor

How to Use Empaphage Tablets 10mg

Take as prescribed by your doctor, typically once daily with or without food. Do not crush or split tablets. Monitor blood glucose regularly. Maintain prescribed diet and exercise plan. Do not discontinue without medical guidance. Contraindicated in severe renal impairment.

Shop related products: Empaphage 25mg Tablets | General Medicines at Derma.pk

Usage & Benefits
  • Contains empagliflozin 10mg — selective SGLT2 inhibitor for T2DM
  • Lowers blood glucose by blocking renal glucose reabsorption
  • Increases urinary glucose excretion for effective glycaemic control
  • Can be used as monotherapy or combined with metformin, insulin, or other antidiabetics
  • Clinically demonstrated to reduce major cardiovascular events in T2DM
  • Prescription-only medicine for medically supervised diabetes management
  • Suitable for adults with type 2 diabetes mellitus
How To Use

1. Take Empaphage Tablets 10mg exactly as prescribed by your doctor.
2. The usual dose is once daily, with or without food.
3. Swallow the tablet whole with water — do not crush, split, or chew.
4. Continue to follow your prescribed diet, exercise, and blood glucose monitoring plan.
5. Do not skip doses or discontinue without your doctor's guidance.
6. Contraindicated in severe renal impairment, end-stage renal disease, or patients on dialysis.

FAQs

What is empagliflozin and how does Empaphage 10mg work?

Empagliflozin is a selective SGLT2 inhibitor that reduces blood glucose by blocking glucose reabsorption in the kidneys, causing excess glucose to be excreted in the urine.

Is Empaphage 10mg a prescription medicine?

Yes. Empaphage 10mg is a prescription-only medicine (Rx). A valid prescription from a registered doctor is required.

Can Empaphage 10mg be used with insulin?

Yes, empagliflozin can be combined with insulin or other antidiabetic agents. However, insulin or sulphonylurea doses may need adjustment to reduce the risk of hypoglycaemia.